Related references
Note: Only part of the references are listed.miR-155-5p Implicates in the Pathogenesis of Renal Fibrosis via Targeting SOCS1 and SOCS6
Wanfen Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis
Mariola Kurowska-Stolarska et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis
Iona C. Evans et al.
CLINICAL SCIENCE (2016)
Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells
Kazuki Shimada et al.
CANCER SCIENCE (2013)
Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis
Ping Li et al.
JOURNAL OF ASTHMA (2013)
Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1
Chen Huang et al.
ONCOLOGY REPORTS (2013)
Overexpression of miR-155 Promotes Proliferation and Invasion of Human Laryngeal Squamous Cell Carcinoma via Targeting SOCS1 and STAT3
Xu-dong Zhao et al.
PLOS ONE (2013)
STAT3-Mediated Signaling Dysregulates Lung Fibroblast-Myofibroblast Activation and Differentiation in UIP/IPF
Dmitri V. Pechkovsky et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis
Robert J. J. O'Donoghue et al.
EMBO MOLECULAR MEDICINE (2012)
Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma
Naoshi Nishida et al.
HEPATOLOGY (2012)
Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells
Yoshihito Souma et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Increased Circulating miR-625-3p A Potential Biomarker for Patients With Malignant Pleural Mesothelioma
Michaela B. Kirschner et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
MicroRNA-155 Modulates Treg and Th17 Cells Differentiation and Th17 Cell Function by Targeting SOCS1
Rui Yao et al.
PLOS ONE (2012)
MicroRNAs in idiopathic pulmonary fibrosis
Kusum V. Pandit et al.
TRANSLATIONAL RESEARCH (2011)
Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells
Chenhe Su et al.
VIROLOGY JOURNAL (2011)
MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene
Shuai Jiang et al.
CANCER RESEARCH (2010)
Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
Guadalupe Ortiz-Munoz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Current clinical trials for the treatment of idiopathic pulmonary fibrosis
Ross C. Klingsberg et al.
RESPIROLOGY (2010)
The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well
C. Z. C. Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions
Nicolas Pottier et al.
PLOS ONE (2009)
Genome-wide DNA methylation profiling using Infinium (R) assay
Marina Bibikova et al.
EPIGENOMICS (2009)
Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats
Tetyana V. Bagnyukova et al.
CELL CYCLE (2008)
Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis
Taku Nakashima et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Expression of SOCS-1 in the liver tissues of chronic hepatitis B and its clinical significance
Zhi-Xin Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice
Yuko Waseda et al.
RESPIRATORY RESEARCH (2008)
Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis
Hiroyasu Shoda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The negative regulatory roles of suppressor of cytokine signaling proteins in myeloid signaling pathways
Samuel Wormald et al.
CURRENT OPINION IN HEMATOLOGY (2007)
The role of IL-6 and STAT3 in inflammation and cancer
DR Hodge et al.
EUROPEAN JOURNAL OF CANCER (2005)
A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells
L O Flowers et al.
ONCOGENE (2005)
Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment
N Khalil et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Angiotensin II and the fibroproliferative response to acute lung injury
RP Marshall et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis
T Yoshida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
SOCS1 and SHP1 hypermethylation in multiple myeloma:: implications for epigenetic activation of the Jak/STAT pathway
CS Chim et al.
BLOOD (2004)
The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse
WS Alexander et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer
B He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells
LX Song et al.
ONCOGENE (2003)
SOCS3 negatively regulates IL-6 signaling in vivo
BA Croker et al.
NATURE IMMUNOLOGY (2003)
Idiopathic pulmonary fibrosis - Relationship between histopathologic features and mortality
TE King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Share Paper
